D. C. Heaton

1.7k total citations
45 papers, 1.3k citations indexed

About

D. C. Heaton is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, D. C. Heaton has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 14 papers in Genetics and 9 papers in Internal Medicine. Recurrent topics in D. C. Heaton's work include Venous Thromboembolism Diagnosis and Management (9 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). D. C. Heaton is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (9 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). D. C. Heaton collaborates with scholars based in New Zealand, United States and Netherlands. D. C. Heaton's co-authors include John A. Snowden, P. H. Fitzgerald, M. E. J. Beard, Kevin McLoughlin, Michael Beard, Christine M. Morris, Peter E. Hollings, Anthony E. Reeve, Christopher M. Morris and Fred G. Behm and has published in prestigious journals such as Nature, Journal of Clinical Oncology and The American Journal of Medicine.

In The Last Decade

D. C. Heaton

45 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D. C. Heaton 572 294 188 168 164 45 1.3k
Shmuel Gillis 532 0.9× 217 0.7× 88 0.5× 84 0.5× 58 0.4× 44 1.1k
Domenico De Mattia 895 1.6× 498 1.7× 127 0.7× 126 0.8× 137 0.8× 87 1.9k
Rendrik F. Franco 1.2k 2.1× 284 1.0× 302 1.6× 388 2.3× 245 1.5× 63 2.1k
R. Egbring 738 1.3× 131 0.4× 145 0.8× 241 1.4× 120 0.7× 66 1.6k
Miguel A. Escobar 877 1.5× 183 0.6× 284 1.5× 118 0.7× 140 0.9× 120 1.8k
Ali Ünal 835 1.5× 389 1.3× 242 1.3× 288 1.7× 160 1.0× 125 2.1k
Ute Hasiba 786 1.4× 216 0.7× 113 0.6× 100 0.6× 43 0.3× 35 1.5k
Mammen Chandy 1.2k 2.1× 343 1.2× 130 0.7× 408 2.4× 124 0.8× 70 1.6k
Angela Thomas 816 1.4× 187 0.6× 253 1.3× 50 0.3× 138 0.8× 53 1.5k
Charles F. Abildgaard 1.3k 2.3× 378 1.3× 166 0.9× 63 0.4× 48 0.3× 49 1.9k

Countries citing papers authored by D. C. Heaton

Since Specialization
Citations

This map shows the geographic impact of D. C. Heaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. C. Heaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. C. Heaton more than expected).

Fields of papers citing papers by D. C. Heaton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. C. Heaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. C. Heaton. The network helps show where D. C. Heaton may publish in the future.

Co-authorship network of co-authors of D. C. Heaton

This figure shows the co-authorship network connecting the top 25 collaborators of D. C. Heaton. A scholar is included among the top collaborators of D. C. Heaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. C. Heaton. D. C. Heaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gough, Sheryl M., et al.. (2006). Translocation (5;10)(q22;q24) in a case of acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 165(1). 36–40. 1 indexed citations
2.
Walker, Logan C., Jane Stevens, Hamish G. Campbell, et al.. (2002). A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia. British Journal of Haematology. 117(4). 878–881. 43 indexed citations
3.
Morris, Christine M., et al.. (2000). Trisomy 10 in Acute Myeloid Leukemia. Cancer Genetics and Cytogenetics. 118(2). 148–150. 7 indexed citations
4.
Hanley, John, et al.. (2000). Hemorrhagic lymphadenopathy as a presenting feature of primary al amyloidosis. Pathology. 32(1). 21–23. 5 indexed citations
5.
Crossen, Peter E., et al.. (1999). Characterization of the C-MYC Amplicon in a Case of Acute Myeloid Leukemia with Double Minute Chromosomes. Cancer Genetics and Cytogenetics. 112(2). 144–148. 11 indexed citations
6.
Egermayer, Paul, et al.. (1998). Usefulness of D-dimer, blood gas, and respiratory rate measurements for excluding pulmonary embolism. Thorax. 53(10). 830–834. 41 indexed citations
7.
Fellowes, Andrew, et al.. (1998). Electrospray ionization mass spectrometry identification of fibrinogen Banks Peninsula (γ280Tyr→Cys): a new variant with defective polymerization. British Journal of Haematology. 101(1). 24–31. 17 indexed citations
8.
Withington, Stephen G, Stephen T. Chambers, M. E. J. Beard, et al.. (1998). Invasive aspergillosis in severely neutropenic patients over 18 years: impact of intranasal amphotericin B and HEPA filtration. Journal of Hospital Infection. 38(1). 11–18. 24 indexed citations
9.
Kunishima, Shinji, et al.. (1997). De novo mutation of the platelet glycoprotein Ib?? gene in a patient with pseudo-von Willebrand disease. Blood Coagulation & Fibrinolysis. 8(5). 311–315. 18 indexed citations
10.
Snowden, John A. & D. C. Heaton. (1997). Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. British Journal of Dermatology. 137(1). 130–132. 44 indexed citations
11.
Heaton, D. C., et al.. (1995). Low Molecular Weight versus Unfractionated Heparin. PharmacoEconomics. 8(2). 91–99. 24 indexed citations
12.
Sandoval, Claudio, Ching‐Hon Pui, Laura C. Bowman, et al.. (1993). Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.. Journal of Clinical Oncology. 11(6). 1039–1045. 147 indexed citations
13.
Crossen, Peter E., et al.. (1993). Cloning and sequencing of a t(14;19) breakpoint that involves the Cμ switch region. Genes Chromosomes and Cancer. 8(1). 60–62. 18 indexed citations
14.
Heaton, D. C., et al.. (1991). Concurrence of hereditary spherocytosis and alpha thalassaemia. Australian and New Zealand Journal of Medicine. 21(4). 485–486. 3 indexed citations
15.
Crossen, Peter E., et al.. (1991). Complex karyotypic evolution in B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics. 57(2). 187–194. 12 indexed citations
16.
Heaton, D. C., et al.. (1989). Ovarian relapse in a young woman with acute lymphoblastic leukaemia. American Journal of Hematology. 30(1). 42–43. 5 indexed citations
17.
Morris, Christopher M., et al.. (1988). Essential thrombocythaemia and the Philadelphia chromosome. British Journal of Haematology. 70(1). 13–19. 40 indexed citations
18.
Crossen, Peter E., et al.. (1987). Chromosome abnormalities in chronic lymphocytic leukemia revealed by cytochalasin B and Epstein-Barr virus. Cancer Genetics and Cytogenetics. 28(1). 93–100. 27 indexed citations
19.
Fitzgerald, P. H., et al.. (1983). Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemia. Cancer Genetics and Cytogenetics. 8(1). 51–66. 60 indexed citations
20.
Darlow, Brian A., et al.. (1980). Bone marrow transplantation for severe aplastic anaemia.. PubMed. 91(653). 86–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026